Shohei Eto

Shohei Eto

Auto-generated profile, based on publicly available information

Shohei Eto

The Department of Surgery The University of Tokushima Tokushima Japan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2021 in Asian Journal of Endoscopic Surgery
Verified
Journal Article
Closed access
PDF file
SEShohei Eto
Shohei Eto
KYKozo Yoshikawa
Kozo Yoshikawa
TYToshiaki Yoshimoto
Toshiaki Yoshimoto
CTChie Takasu
Chie Takasu
HKHideya Kashihara
Hideya Kashihara
MSMitsuo Shimada
Mitsuo Shimada

3 August 2017 in International Surgery
Verified
Journal Article
Open access
SEShohei Eto
Shohei Eto
KYKozo Yoshikawa
Kozo Yoshikawa
TITakashi Iwata
Takashi Iwata
JHJun Higashijima
Jun Higashijima
TTTakuya Tokunaga
Takuya Tokunaga
TKToru Kono
Toru Kono
Crohn disease (CD) is a chronic inflammatory bowel disease that affects the entire gastrointestinal tract. The standard treatment for CD is medication to control the inflammation and relieve the symptoms. CD patients often require surgery at some point in their life for complications, treatment resistance, and side effects of medication. However, postoperative recurrences are common. To reduce anastomotic troubles, several types of anastomosis were investigated. Kono-S anastomosis, an antimesenteric, functional, end-to-end handsewn anastomosis, was introduced in order to prevent the restenosis caused by recurrence of CD in 2010. Kono-S anastomosis is expected lower susceptibility to mechanical distortions due to the stability provided by the “supporting column.” We herein report 2 cases of CD performed with a Kono-S anastomosis. The importance of these cases is that Kono-S anastomosis is useful for preventing restenosis caused by recurrence. The first patient was a 26-year-old man who suffered from CD for 9 years. Computed tomography (CT) showed inflammation and stenosis at the ileocecum, a fistula between the terminal ileum and sigmoid colon, and an intraperitoneal abscess. We performed an ileocecal resection and a Kono-S anastomosis. The second patient was a 25-year-old woman who suffered from CD for 8 years. CT showed inflammation and stenosis at the ileocecum, and a retroperitoneal abscess. We performed an ileocecal resection and Kono-S anastomosis. Both patients showed no recurrence after surgery. Kono-S anastomosis may be effective for preventing recurrence at anastomotic sites in CD patients.

20 January 2015 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
SEShohei Eto
Shohei Eto
TITakashi Iwata
Takashi Iwata
KYKozo Yoshikawa
Kozo Yoshikawa
JHJun Higashijima
Jun Higashijima
TNToshihiro Nakao
Toshihiro Nakao
MSMitsuo Shimada
Mitsuo Shimada
31 Background: PD-1 (Programmed Death 1), a member of the B7-CD28 family, is a cell surface coinhibitory receptor expressed on T cells, B cells, monocytes, and natural killer T cells, following activation. Recently, PD-1 expression is involved with malignancy have been reported in cancer cells and virus-infected cells. The aim of this study is to clarify the impact of PD-1 expression on long term outcome of gastric cancer. Methods: Total of 105 patients who were performed gastrectomy in Stage 2/3 gastric cancer. For resected specimen was performed immunostaining of PD-1. We counted PD-1 positive T cells in the tumor across five adjoining high power fields (×400 magnification level). And, we calculated the percentage of the total cell number, it was considered PD-1 positive more than 40%. We investigated clinicopathological factors and survival. Results: 28 cases were PD-1 positive expression. There was no significant difference between the two groups in the clinicopathological factors (age, gender, tumor size, differentiation, depth of invasion, lymph node metastasis, stage, lymphatic invasion and venous invasion). There was no difference in overall survival rate at 3 years (PD-1 positive vs. negative 76% vs. 81%, p=0.552). PD-1 positive expression was significantly poorer in disease-free survival rate (36% vs. 65%, p=0.022). 10 cases were Foxp3 positive expression, and Foxp3 positive expression was related with PD-1 expression. Conclusions: The PD-1 expression in the tumor could be a potential prognostic factor in gastric cancer.

1 April 2020 in The Japanese Journal of Gastroenterological Surgery
Verified
Journal Article
Open access
PDF file
TTTakao Tsuneki
Takao Tsuneki
YYYasuhiro Yuasa
Yasuhiro Yuasa
HMHidenori Maki
Hidenori Maki
TTTaihei Takeuchi
Taihei Takeuchi
YMYuta Matsuo
Yuta Matsuo
YFYoshiyuki Fujii
Yoshiyuki Fujii
症例は70歳の男性で,上部消化管内視鏡にて胃角部小彎に0-IIa+IIc型早期胃癌を指摘され,当科を紹介受診した.腹腔鏡下幽門側胃切除を施行し病理結果は以下であった〔pT1bN2M0,pStage IIA,HER2(IHC2+,FISH陽性)〕.術後経過観察を行ったが,8か月後に肝外側区域に異時性肝転移が出現した.S-1+cisplatin+trastuzumab療法を3コース施行し,腫瘍縮小効果が得られた.新規病変の出現も認めなかったため腹腔鏡下肝部分切除を施行した.術後,S-1を1年間内服し約4年経過した現在も無再発生存中である.HER2陽性胃癌術後の単発肝転移に対して化学療法後に腹腔鏡下肝部分切除を施行した1例を経験したので報告する.